Oura launches redesigned app and ‘Cumulative Stress’ feature

Oura announced Monday that it’s launching a redesigned app experience and an “increasing stress” feature. The company also shared that it is pursuing FDA clearance for blood pressure features that assess users’ likelihood of high blood pressure.

The redesigned Oura app introduces more personalization with three main tabs. The “Today” tab shows the most relevant insights for day-to-day decisions, and the “Vitals” tab provides an at-a-glance view of things like sleep, stress, and cardiovascular trends. The “My Health” tab offers insights into the user’s long-term wellness, highlighting strengths, trends and opportunities for proactive care. The tab also includes “Habit” and “Routine” sections to show the effects of daily tasks.

The app redesign also brings improved menstrual cycle insight with 12-month period and fertile window predictions from the previous month view.

The new cumulative stress feature helps users understand how their body accumulates and responds to chronic stress over time. It provides a stress measure based on last month’s data and is updated weekly. A person’s cumulative pressure is determined by five factors: sleep continuity, heart pressure response, sleep micro-motion, temperature regulation and activity effects.

“It’s much more than just counting the hours spent during stressful times,” Jason Russell, Aura’s VP of consumer software products, told TechCrunch. “It’s actually measuring different physical activities that indicate increasing stress on your body. So how your heart rate and heart rate variability reacts after a stressor is indicative of increasing stress. Your thermodynamics. How you regulate your temperature overnight, how uninterrupted your sleep is. Whatever you experience, we feel, is not large movement during sleep, so not large movement during sleep. Little signatures that will indicate your body is growing high. facing pressure.”

The new feature will roll out globally next week.

On the way to developing an FDA-approved blood pressure feature, Oura announced that it is introducing a new blood pressure profile study to explore how the company can detect early signs of high blood pressure by passively tracking key signals in the background.

Oura received institutional review board approval for the study, which is being rolled out later this year at experimental hub Oura Labs in the US. Users who are part of the study will be informed of their current likelihood of high blood pressure by combining Oura Ring data with a brief check-in questionnaire on their family history, medications and lifestyle habits. They will receive an assessment that will tell them whether they have no symptoms, moderate symptoms or major symptoms of high blood pressure.

Members with severe symptoms are encouraged to seek professional medical care. The algorithm will also track changes over time, prompting periodic reviews across studies, Ora says.

Monday’s announcement came a week later They raised $900 million The new financing was led by Fidelity Management & Research Company, with contributions from new investors ICONIQ and Whale Rock and Atreides.

This also comes when they launched it recently Oura Ring 4 Ceramic CollectionIts first charging case, and a new Health Panel feature that allows members to schedule blood work directly in the Oura app